May 19, 2024

Meningococcal meningitis Symptoms, Prevention, Causative agent

Meningococcal meningitis Symptoms, Prevention, Causative agent

Epidemiology:

Meningococcal meningitis is observed worldwide; the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Meningococcal meningitis is associated with high fatality (50% when untreated) and high frequency (10-20%) of severe long-term sequelae. Early antibiotic treatment is the most important measure to save lives and reduce complications. Serogroup specific vaccines are used for prevention and in response to outbreaks. Since 2010 and the roll-out of a meningococcal A conjugate vaccine through mass preventive immunization campaigns in the meningitis belt, the proportion of the A serogroup has declined dramatically.

Causative agent :

Neisseria meningitis

Signs and symptoms:

Headache, vomiting, stiff neck and progress within a few hours

Incubation period

3-4 days

Mode of Transmission

Droplet infection

Prevention and Control

Isolation 

Penicillin is the drug of choice

Chemoprophylaxis is suggested for close contact persons.

Immunization

Prevention of overcrowding is a long term measure


F Y D Pharm Notes, Books, Syllabus, PDF, Videos

S. No.Name of the Course
1.ER20-11T Pharmaceutics Theory
2.ER20-11P Pharmaceutics Practical
3.ER20-12T Pharmaceutical Chemistry Theory
4.ER20-12P Pharmaceutical Chemistry Practical
5.ER20-13T Pharmacognosy Theory
6.ER20-13P Pharmacognosy Practical
7.ER20-14T Human Anatomy & Physiology Theory
8.ER20-14P Human Anatomy & Physiology Practical
9.ER20-15T Social Pharmacy Theory
10.ER20-15P Social Pharmacy Practical
F Y D Pharm Syllabus

Suggested readings

Recommended readings:

  • Paramedics on the Front Line: Recognizing and Responding to Myocardial Infarction

  • Pre-eclampsia and Screening: Identifying Risks for a Healthier Pregnancy

  • Exploring Sugar Substitutes like Neotame, Aspartame, and Saccharin